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http://dx.doi.org/10.1016/j.jfma.201Background/Purpose: Screening colonoscopy is one of the most effective methods to detect
and prevent colorectal cancer by removing neoplastic polyps. The recent discovery of serrated
polyps with neoplastic potential has reclassified these polyps into hyperplastic polyps (HPs),
sessile serrated adenoma (SSA), and traditional serrated adenoma (TSA) on the basis of macro-
scopic morphology and microscopic histology. In this study, we aimed to revisit HPs identified
during screening endoscopy by histological reevaluation and genetic alterations.
Methods: A total of 253 HPs found by screening endoscopy were rechecked by two patholo-
gists, and mutual agreement on the diagnosis of polyps was subjected for further statistical
analysis. Direct sequencing for gene mutation at BRAF V600E and KRAS G12D was performed.
Results: Among the 253 HPs analyzed, 175 were classified as serrated polyps, while 78 were
reclassified into other diagnosis. The concordance among pathologists in diagnosing these
serrated polyps was substantial (k Z 0.6672). About 11.5% of the reviewed HPs turned out
to be with neoplastic potential, including 7 SSAs, 5 TSAs, as well as 17 conventional adenomas.
Results of subgroup analyses revealed that polyps >10 mm were more likely to be found in
proximal colon (p Z 0.0006) and tended to harbor neoplastic components. We found that
two SSAs and one TSA had BRAF mutation, while one TSA had KRAS mutation. The mean size
of these mutated adenomas (9.0 mm) was larger than those with wild-type genes (4.9 mm).
Conclusion: Serrated polyps with neoplastic potential were prone to be overlooked as hyper-
plastic and innocent ones during screening colonoscopy. Therefore, both endoscopists andave no conflicts of interest relevant to this article.
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418 Y.-C. Lin et al.pathologists should pay attention to understand the importance of recognizing serrated
adenomas, especially for those polyps >10 mm, or those that are located in the proximal
colon.
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The prevalence of colorectal cancer (CRC) has increased
dramatically in the Asia-Pacific region. In Taiwan, CRC now
ranks as the third leading cause of cancer death. The
concept of adenomaecarcinoma sequence is the core of
current screening, surveillance, and prevention measures
for CRC.1 Accumulating evidence indicates that colono-
scopic detection and removal of adenomatous polyps are
effective in preventing CRC development and decreasing
its mortality.2e4 The potential of hyperplastic polyps (HPs)
to progress to adenomas had been considered low since
1960s, and thus it seems reasonable to leave these inno-
cent lesions in situ.5 The present guidelines for colon
cancer screening postulated that upon finding of HPs in the
sigmoid colon or rectum, the surveillance interval was 10
years, the same as those in which no HPs were found in the
colon.6 However, a group of polyps with histological
features similar to that of serrated crypts was described to
have neoplastic potential since 1990 by Longacre and
Fenoglio-Preiser. They first described some serrated
polyps could have cytological dysplasia, and designated
such polyps as “serrated adenoma”. These pedunculated
lesions are now known as “traditional serrated adenoma”
(TSA), predominantly located in the distal colon.7 In 2003,
Torlakovic and colleagues demonstrated that some
serrated polyps, with sessile or flat appearance, were
more likely to reside in the proximal colon. The crypt
branching and dilatation at the basal area of these lesions
made them distinct from the HPs and TSAs.8 Such sessile
serrated adenomas (SSAs) might progress to serrated
cancers, comprising 10e20% of CRC, and 30% of interval
cancers.9 The molecular pathogenesis of serrated cancers
was known as “serrated pathway”, in which microsatellite
instability (MSI), BRAF V600E mutation, and high CpG
island methylation (CIMP-H) played crucial roles.10
Because of their unique macroscopic and microscopic
characteristics, SSAs might be overlooked either endo-
scopically or histologically. In general, polyps presenting
saw tooth-like appearance within crypts are referred to as
serrated polyps, which might result from migration of
proliferation zones from the basal membrane upward to
the middle and upper part of the crypts. Currently, HP,
TSA, and SSA were classified as serrated polyps based on
the 4th Edition World Health Organization bluebook pub-
lished in 2011.
In clinical practice, endoscopists normally perform
biopsies for polyps <5 mm in size and perform poly-
pectomies or endoscopic mucosal resection (EMR) for
suspicious neoplastic lesions if appropriate. It is not
uncommon to encounter discrepancy between endoscopic
and histological diagnosis, especially after the introduction
of serrated polyp into HP, TSA, and SSA. Results ofhistological examination revealed that some of these
serrated adenomas turned out to be HPs, while some HPs
were diagnosed to be serrated adenoma. Moreover, the
interobserver variation between pathologists remains an
important issue and makes the problem more compli-
cated.11 There are only a few systemic investigations of
serrated polyps in Chinese population. Therefore, we
aimed to review HPs identified during screening endoscopy
by histological reevaluation and genetic alterations.Methods
Studied cases
We studied histologically diagnosed HPs found during
screening colonoscopy in Health Management Center of
National Taiwan University Hospital in 2007. The enrolled
data included age, sex, location, size, methods by which
the specimen were collected, morphology, and histology of
polyps.Those with incomplete documentation of size,
location or histology of polyps were excluded from the
study. From January to December 2007, a total of 253 HPs
were eligible for investigation, while 5 HPs were excluded
due to lack of data.Colonoscopic findings
Endoscopic morphology of the polyps was categorized using
the Paris endoscopic classification: protruded or peduncu-
lated polyps as “0-Ip”, intermediate or semipedunculated
ones as “0-Isp”, sessile lesions as “0-Is”, and those super-
ficially elevated as “0-IIa”. There were no HPs designated
as 0-IIb (flat), 0-IIc (depressed), or 0-III in our database.
Size estimation was based on the comparison of index
lesions with forceps size and on the judgment of colono-
scopists. Polyp locations were classified into two groups:
proximal was defined as the cecum, ascending colon, and
the transverse colon; and distal was defined as the
descending colon (including the splenic flexure), sigmoid
colon, and the rectum.Pathologic findings
Histological reviews were performed by pathologists who
specialized in gastrointestinal pathology. The histological
slides were reviewed independently by two pathologists,
who were informed to reevaluate the cases with initial
diagnosis of HPs. The reevaluated diagnosis was designated
as HP, SSA, TSA, tubular adenomas (TAs), and tubulovillous
adenomas (TVAs).
Table 1 Characteristics of the study population.
Variable Enrolled
polyps
Serrated
polyp group
Sex N Z 253 N Z 175
Male 167 (66%) 117 (67%)
Female 86 (34%) 58 (33%)
Age (y)
Mean (SD) 51.95 (11.36) 51.83 (11.19)
<30 1 1
30e39 39 29
40e49 65 47
50e59 86 60
60e69 49 30
70e79 10 6
80 3 2
Polyp mean size (SD) 4.53 (0.34) 4.71 (0.31)
10 mm N Z 14 N Z 11
6e9 mm (small) N Z 38 N Z 27
1e5 mm (diminutive) N Z 201 N Z 137
Revision
Hyperplastic polyp 163 163
TSA 5 5
SSA 7 7
TA 17 d
Inflammatory polyp 58 d
Mucosa tag 3 d
SD Z standard deviation; SSA Z sessile serrated adenoma;
TSA Z traditional serrated adenoma; TA Z tubular adenoma.
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DNA was extracted from the polyps with neoplastic poten-
tial using Tri-Solution Reagent Plus (GeneMark Technology,
Tainan, Taiwan) following the manufacturer’s instruction
and was stored at 80C until use. Codons 12 and 13 of the
KRAS and exon 15 of BRAF genes were evaluated for
mutation as previously reported.12 In brief, each exon was
amplified by polymerase chain reaction (PCR) using the
oligonucleotide primers for sequencing KRAS and BRAF
based on previously published sequences. The primer
sequences used for the detection of KRAS mutations were
forward 50-CTGAAAATGACTGAATATAAACTTGT-30 and
reverse 50-ATATGCATATTAAAACAAGATTTACC-30 for codons
12 and 13. The primer sequences used for the detection of
BRAF mutations were forward 50-TGCTTGCTCTGATAG
GAAAATG-30 and reverse 50-GCATCTCAGGGCCAAAAATTT-30.
The PCR products were then purified and subjected to
direct sequencing using the automatic sequencer (ABI
PRISM 3100 Genetic Analyzer, Applied Biosystems, Foster
City, CA 94404, USA).
Statistical analysis
We used c2 test and Fisher exact test for analyzing the
association between neoplastic polyps and the sex, polyp
size, and polyp distribution. Kappa value was calculated to
evaluate interobserver concordance. A p value <0.05 was
considered to be statistically significant.Table 2 Relations of serrated polyp size, location and sex
versus neoplastic and non-neoplastic polyps.
Number
of polyps
Neoplastic Non-
neoplastic
p
Size Small 10 154 0.167a
Large 2 9
Location Proximal 5 66 1.00a
Distal 7 97
Sex Female 3 54 0.753a
Male 9 109
a Fisher’s exact test, two-tailed.Results
Characteristics of the reviewed population and
morphology of the polyps
Of the 253 polyps eligible for reevaluation of histology, 47
were polypecomized, 201 were biopsied using biopsy
forceps, and 5 polyps were removed via EMR. A total of 167
(66%) polyps were from men and 86 (34%) from women, with
a mean age of 52.0 years. Macroscopically, 206 polyps were
described as sessile or flat polyp (IIa, Is, Isp), and 15 polyps
were described as protruded type (Ip), while 32 polyps had
missing data about morphology. Among them, 14 (5.6%)
were large polyps (size 10 mm), 38 (15.0%) were inter-
mediate polyps (size: 6e9 mm), while 201 (79.4%) were
diminutive polyps (size: 1e5 mm). After the reevaluation of
histological slides by pathologists, 5 TSAs, 7 SSAs, and 17
conventional (tubular or tubulovillous) adenomas were
found. The serrated polyps were categorized into a specific
group for detailed analysis (Table 1). Different diagnosis
among the two pathologists arose from several aspects,
especially when intermediate cytological and architectural
features were encountered. There remain gray zones for
definite diagnosis of serrated polyps merely according to
cytological and architectural features especially when the
specimen was relative small in size, and so there were 12
HPs with atypical serrated epithelium, which represented
some HPs with architectural change but had not met the
criteria for being serrated adenoma. The concordance
between the two pathologists was substantial (kZ 0.6672,95% confidence interval: 0.445e0.889) on the diagnosis of
serrated polyps.
The mean size of five TSAs was 6.8 mm, and 80% was
located in the distal colon. Of the seven SSAs, the mean size
was 5.9 mm, and 57.1% were in the proximal colon. Of the
serrated polyps, those> 10 mm were more likely to be
located in the proximal colon (p Z 0.0006, Fisher exact
test), and tended to harbor neoplastic potential (18.2%)
than smaller ones (6.1%, p Z 0.167). No difference was
found between presence of neoplastic polyps and sex
(p Z 0.236) or location (p Z 1.000) (Table 2).
Genetic alterations
The BRAF and KRAS mutations were evaluated for 7 SSAs, 5
TSAs, and 17 TAs. Two of the seven SSAs (28.6%) were found
Table 4 Serrated polyps and BRAF or KRAS mutations.
Polyp type BRAF
mutation
KRAS
mutation
BRAF/KRAS
mutations
SSA (n Z 7) 2 (28.6%) 0 2 (28.6%)
TSA (n Z 5) 1 (20%) 1 (20%) 2 (40%)
HP (n Z 35) 0 0 0
TA/TVA (n Z 17) 0 0 0
420 Y.-C. Lin et al.to have BRAF V600E mutation; the mean size of adenomas
bearing BRAF mutation was 8.0 mm, and those with wild-
type BRAF was 5.0 mm. One of the five TSAs (20%) had
BRAF mutation, while one of the five TSAs (20%) had KRAS
mutation; the average size of polyps bearing mutations was
10 mm, in contrast to 4.7 mm for those with wild-type BRAF
and KRAS (Table 3). None of the tubular or TVAs had BRAF
V600E or KRAS mutation (Table 4).HP Z hyperplastic polyp; SSA Z sessile serrated adenoma;
TA Z tubular adenoma; TSA Z traditional serrated adenoma;
TVA Z tubulovillous adenoma.Discussion
Many studies and guidelines have suggested that detection
and removal of adenomas by screening colonoscopy were
the key to prevent CRCs.1,13 The majority of HPs were
regarded harmless and had little potential to progress to
neoplasms.5 In this study, 253 polyps diagnosed as HPs
during screening colonoscopy were reevaluated by histo-
logical analysis. Our analysis revealed 29 (11.5%) cases to
be neoplastic polyps. Among these neoplastic polyps, 17
(6.7%) were conventional adenomas, while TSAs and SSAs
together accounted for 4.7% (n Z 12) of the polyps. This
study was the first one specified to reveal possible
“hidden” serrated adenomas among HPs in a Chinese
population. Our results indicated that a substantial
portion of neoplastic polyps might be missed even after
histological examinations.
Several factors are attributed to the underdiagnosis of
the neoplastic polyps, especially for serrated adenomas.
First, the concept of serrated polyp and adenoma was not
adopted by every pathologist. The concept of serrated
adenomas as a different polyp entity was postulated in 1990
by Longacre and Fenoglio-Preiser. In their report on the
review over 18,000 polyps resected or biopsied, 0.6% turned
out to be serrated adenomas.7 They referred the polyps as
mixed hyperplastic adenomatous polyps. Thereafter, many
pathologists had similar observations of this polyp entity,
but had different descriptions such as large HPs with focal
adenomatous change, polyps with admixture of adenoma-
tous and hyperplastic glands, or hybrid polyps. It took
decades for pathologists to reach a consensus and embrace
the concept of SSAs. However, diagnostic challenges exist.
The complicated morphological variables in differentiating
SSAs and TSAs from HPs even confused pathologists.14 The
major and frequently described histological features in
serrated polyps were incorporated in the diagnosis of
pathologists, however, some polyps may harbor interme-
diate architectural or cytological features and gray-zonesTable 3 Serrated adenomas with BRAF or KRAS
mutations.
Polyp
type
BRAF V600E KRAS G12D Size (mm) Location
SSA GAG d 10 T colon
SSA GTG/GAG d 6 S colon
TSA GTG/GAG d 18 D colon
TSA d GGT/AGT 2 Rectum
SSA Z sessile serrated adenoma; TSA Z traditional serrated
adenoma.were noted in the diagnosis of these serrated polyps.
Thus, the concordance in diagnosis of serrated adenomas
among pathologists might be unsatisfactory. Difficulties
also arise if subjected specimens were incomplete or
fragmented. Farris et al pointed out that dilatation without
serration at crypt bases or other characteristic features of
SSA was particularly problematic to most observers.11
Compared with the previous reports of Farris and
colleagues (highest k Z 0.58 in three rounds), our results
showed substantial concordance between pathologists in
the diagnosis of serrated polyps. The difference might
result partly from the number of raters.
Serrated polyps displayed different genetic alterations
from conventional TAs.14,15 In this study, we selected those
polyps with neoplastic potential for direct sequencing of
point mutation of BRAF V600E and KRAS G12D. Previous
reports have documented that BRAF mutation was associ-
ated with serrated adenomas (either traditional or sessile).
A high prevalence of serrated polyps with BRAF mutations
had been documented in previous studies, ranging from 78%
to 90%. However, the mutation rate in our study was lower
compared with previous literature (28% in SSA and 40% in
TSA). Because mutation rate will depend on size and stage
of the neoplastic polyps, small number and size of our study
polyps might partly contribute to such discrepancy. More-
over, our targeted polyp was those diagnosed as HPs,
indicating those diagnosed as SSA or TSA in the first place
were excluded in our study. Therefore, those large polyps
with a high prevalence of mutations might be excluded.
Detailed analysis regarding BRAF/KRAS mutations relative
to polyp size had been done in one study,15 which revealed
that the percentage of positive BRAF and KRAS mutations
was higher in large serrated polyps (>10 mm). In agreement
with these reports, we have indeed found that serrated
adenomas with genetic alterations in BRAF or KRAS genes
had larger size than those with wild-type genes (9.0 mm vs.
4.9 mm).
Current guidelines recommend the interval for surveil-
lance colonoscopy of “no polyps” and “HPs” at rectum to
sigmoid colon to be 10 years.6,16 Nevertheless, interval
cancers have been reported to be 0.3e0.9% within 3e5
years in patients who had complete polypectomy.17 Missed
lesions, incomplete polypectomy, or rapidly growing
cancers were among the causes that lead to interval
cancers. Intriguingly, the interval cancers are predomi-
nantly located in the proximal colon and are four times the
incidence of CIMP-H and/or MSI, both of which are features
of serrated pathway cancers.18,19 Taken together, these
Hyperplastic polyps reevaluated 421data implicated that underdiagnosis of serrated lesions may
be relevant to the occurrence of interval cancer. The
screening and surveillance strategies toward serrated
adenomas are currently lacking.20 A 5-year interval
surveillance might be reasonable and was suggested.21 This
was similar to the interval for patients with one to two TAs
<10 mm.21,22 Two recent studies have demonstrated the
importance of recognizing the presence of large serrated
polyps and implicated that the surveillance guidelines
should be updated.23,24
There are certain limitations in our study. First, we
retrospectively enrolled patients scheduled for screening
colonoscopies. Because of the small size of polyps, the
selected patients underestimated the prevalence of
serrated polyps in our study as compared with 18e22% in
previous literatures. Second, different modalities of colo-
noscopy and the extent of colon cleansing were crucial
factors in identification of flat colon lesions and will result
in the heterogeneity of the diagnostic results. Some polyps
with missing data of morphology might raise certain
concerns. Finally, the concept of serrated polyps was not
adopted by our pathologists before 2008. A prospective
study with standard protocol and histological criteria is
warranted to further clarify the role of serrated polyps in
screening setting and different population.
In summary, we have demonstrated that a total of 11.5%
HPs in screening colonoscopy finally turned out to be polyps
with neoplastic potential. Only 175 out of 253 polyps were
serrated polyps, and there remained room for improvement
of the pathologic diagnosis in general practice. Fair
agreement among pathologists in differentiating subgroups
of serrated polyps was noted in our study. In agreement
with previous reports, we found that SSAs were predomi-
nantly located in the proximal colon, while the TSAs in the
distal colon. Both endoscopists and pathologists should pay
attention to recognize the importance of serrated
adenoma, especially for those polyps> 10 mm, or located
in the proximal colon.References
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